Physical Activity and Glycemic Control

This study has been completed.
Sponsor:
Information provided by:
University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT00881972
First received: April 14, 2009
Last updated: March 30, 2011
Last verified: March 2011
  Purpose

This study will test the effects of daily physical activity on variations in blood glucose control.


Condition Intervention
Insulin Resistance
Behavioral: Exercise

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Physical Activity and Glycemic Control

Resource links provided by NLM:


Further study details as provided by University of Missouri-Columbia:

Primary Outcome Measures:
  • Blood glucose fluctuations [ Time Frame: days ] [ Designated as safety issue: No ]

Estimated Enrollment: 75
Study Start Date: February 2009
Study Completion Date: July 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: exercise Behavioral: Exercise
walking/running/cycling

  Eligibility

Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Young, healthy

Exclusion Criteria:

  • Chronic disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00881972

Locations
United States, Missouri
University of Missouri-Columbia
Columbia, Missouri, United States, 65201
Sponsors and Collaborators
University of Missouri-Columbia
Investigators
Principal Investigator: John P Thyfault, PhD Univerisity of Missouri-Columbia
  More Information

No publications provided

Responsible Party: Dr. John Thyfault, University of Missouri-Columbia
ClinicalTrials.gov Identifier: NCT00881972     History of Changes
Other Study ID Numbers: 1116098
Study First Received: April 14, 2009
Last Updated: March 30, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on April 23, 2014